Literature DB >> 9261413

Sequence variation within a nonstructural region of the hepatitis G virus genome.

Y E Khudyakov1, M E Cong, M T Bonafonte, S Abdulmalek, B L Nichols, S Lambert, M J Alter, H A Fields.   

Abstract

Nine sets of nested PCR primers from a 2.6-kb region of the hepatitis G virus (HGV) genome at nucleotide positions 5829 to 8421 were designed and used to analyze serum specimens obtained from patients with community-acquired non-A, non-B hepatitis who were HGV RNA positive. One set of primers was found to be most efficient in detecting HGV and was subsequently used to test 162 HCV-positive and 11 HCV-negative plasma units obtained from individual paid donors. HGV RNA was detected in 30 (17.3%) plasma units, 2 of which were found among the 11 HCV-negative specimens. A complete set of nine PCR fragments was obtained from two patients with community-acquired acute non-A, non-B hepatitis and from four paid donors. All PCR fragments were sequenced and were shown to have a nucleotide similarity of 85.9 to 92.3% and a derived amino acid similarity of 96.0 to 99.0%. The majority of nucleotide changes occurred in the third position of codons. The HGV nucleotide and protein sequences obtained in this study were compared with HCV sequences. Based on this analysis the 2.6-kb fragment was predicted to encode the C-terminal part of the putative NS4b, the entire NS5a, and almost the complete NS5b proteins. Putative protease cleavage sites separating these proteins were also predicted. In serial specimens obtained from the two HGV-infected patients, no significant variations were found in the HGV nucleotide and derived amino acid sequences over time. The HGV sequences obtained from one patient showed no changes over 6 months, whereas more than 99.0% homology was observed for sequences from the second patient over 2.5 years. Heterogeneity analysis performed on 10 sequences obtained in this study and corresponding regions from 6 known full-size sequences of the HGV genomes demonstrated notable discrete heterogeneity consistent with the existence of HGV genetic groups or types.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261413      PMCID: PMC191969     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis.

Authors:  A S Muerhoff; T P Leary; J N Simons; T J Pilot-Matias; G J Dawson; J C Erker; M L Chalmers; G G Schlauder; S M Desai; I K Mushahwar
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

2.  GBV-C in the aetiology of fulminant hepatitis.

Authors:  J H Kao; P J Chen; D S Chen
Journal:  Lancet       Date:  1996-01-13       Impact factor: 79.321

3.  Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology.

Authors:  M Yoshiba; H Okamoto; S Mishiro
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

4.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

5.  Temporal relationships of hepatitis C virus RNA and antibody responses following experimental infection of chimpanzees.

Authors:  M J Beach; E L Meeks; L T Mimms; D Vallari; L DuCharme; J Spelbring; S Taskar; J B Schleicher; K Krawczynski; D W Bradley
Journal:  J Med Virol       Date:  1992-03       Impact factor: 2.327

6.  Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions.

Authors:  F Deinhardt; A W Holmes; R B Capps; H Popper
Journal:  J Exp Med       Date:  1967-04-01       Impact factor: 14.307

7.  Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites.

Authors:  A Grakoui; D W McCourt; C Wychowski; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

8.  Isolation of novel virus-like sequences associated with human hepatitis.

Authors:  J N Simons; T P Leary; G J Dawson; T J Pilot-Matias; A S Muerhoff; G G Schlauder; S M Desai; I K Mushahwar
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

9.  Classification of hepatitis C virus into major types and subtypes based on molecular evolutionary analysis.

Authors:  K Ohba; M Mizokami; T Ohno; K Suzuki; E Orito; Y Ina; J Y Lau; T Gojobori
Journal:  Virus Res       Date:  1995-05       Impact factor: 3.303

10.  Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes.

Authors:  H Okamoto; K Kurai; S Okada; K Yamamoto; H Lizuka; T Tanaka; S Fukuda; F Tsuda; S Mishiro
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

View more
  5 in total

1.  A high frequency of GBV-C/HGV coinfection in hepatitis C patients in Germany.

Authors:  Jie Yan; Reinhard H Dennin
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Hepatitis G virus infection in Amerindians and other Venezuelan high-risk groups.

Authors:  F H Pujol; Y E Khudyakov; M Devesa; M E Cong; C L Loureiro; L Blitz; F Capriles; S Beker; F Liprandi; H A Fields
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Diversity of hepatitis G virus within a single infected individual.

Authors:  L Shao; H Shinzawa; X Zhang; D B Smith; H Watanabe; H Mitsuhashi; K Saito; T Saito; H Togashi; T Takahashi
Journal:  Virus Genes       Date:  2000-10       Impact factor: 2.332

4.  HCV and HGV infection in Hodgkin's disease.

Authors:  Katalin Keresztes; Mária Takács; Margit Horányi; Zsófia Miltényi; Arpád Illés
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

5.  Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication.

Authors:  Jinhua Xiang; James H McLinden; Qing Chang; Emma L Jordan; Jack T Stapleton
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.